Focinvez is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Focinvez is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameFocinvez
Authorized genericfosaprepitant dimeglumine
Regular genericfosaprepitant dimeglumine
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Focinvez?
The original
–
–

Brand nameThe maker’s card

Amneal PATHways Co-Pay Savings Program

Savings card from Amneal Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a treatment

Sign up on focinvez.us 

Or call 1-866-426-6325.

In the maker’s words

“Eligible, commercially insured patients may pay as little as $0 per treatment with an Amneal Biosciences product.”

From the maker’s offer on focinvez.us, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Focinvez itself, from the same company, sold without the brand name, and usually for less. For now Focinvez is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

FOCINVEZ is a substance P/neurokinin-1 (NK1) receptor antagonist, indicated in adults and pediatric patients 6 months of age and older, in combination with other antiemetic agents, for the prevention of:

  • acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin.
  • delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC).

Limitations of Use

  • FOCINVEZ has not been studied for treatment of established nausea and vomiting.

Source: the FDA label for Focinvez (Amneal Pharmaceuticals LLC), September 18, 2026. Full label on DailyMed 

Good to know